Intriguingly, the above results confirmed that targeting CCL20 by miR-143-5p alleviated lead acetate-induced renal fibrosis by regulating fibroblast proliferation and dysfunction, indicating a promising therapeutic approach for renal fibrosis. Here, CCL20 is linked to renal fibrosis.